Premium Nahrungsergänzungsmittel | artgerecht

Telomere Biology Therapy – Explanation & Research

Telomere biology therapy is an innovative research approach aimed at lengthening and protecting telomeres in order to slow down aging processes and treat age-related diseases.

Regular tips about health Regular tips about health

Things worth knowing about "Telomere Biology Therapy"

Telomere biology therapy is an innovative research approach aimed at lengthening and protecting telomeres in order to slow down aging processes and treat age-related diseases.

What is Telomere Biology Therapy?

Telomere biology therapy is a modern medical and scientific approach focused on the targeted manipulation of telomeres. Telomeres are protective caps located at the ends of chromosomes – similar to the plastic tips on shoelaces – that prevent genetic material from being damaged during cell division. With each cell division, telomeres shorten progressively until the cell eventually enters a state of dormancy (senescence) or dies. Telomere biology therapy aims to slow, halt, or even reverse this process.

Biological Foundations

Telomeres consist of repetitive DNA sequences (TTAGGG in humans) and associated proteins known as the shelterin complex. The enzyme telomerase is capable of re-lengthening shortened telomeres. However, in most adult somatic cells, telomerase is inactive, leading to progressive telomere shortening. In stem cells, germ cells, and cancer cells, telomerase remains active.

Telomeres and Aging

Short telomeres are associated with a wide range of age-related diseases, including cardiovascular disease, type 2 diabetes, neurodegenerative disorders, and immune system decline. Scientific studies show that individuals with shorter telomeres tend to have a lower life expectancy on average compared to those with longer telomeres.

Therapeutic Approaches and Mechanisms of Action

Telomere biology therapy encompasses various experimental and clinically investigated strategies:

Telomerase activation: Certain molecules such as TA-65 (a cycloastragenol derivative from the plant Astragalus membranaceus) are intended to activate telomerase and thereby lengthen telomeres. TA-65 is one of the most well-known and best-studied compounds in this field.
Gene therapy approaches: In animal studies (particularly in mice), telomerase genes have been successfully introduced into cells using viral vectors, resulting in measurable telomere lengthening and improvement of age-related symptoms.
Senolytic therapies: These approaches aim to selectively eliminate senescent cells with very short telomeres, as these cells secrete pro-inflammatory signaling molecules and contribute to tissue aging.
Epigenetic modulators: Substances that influence telomerase gene expression through epigenetic mechanisms are also being investigated.
Lifestyle modifications: Scientific evidence indicates that regular physical activity, a balanced diet (e.g., Mediterranean diet), stress reduction, and adequate sleep can slow telomere attrition.

Areas of Application

Telomere biology therapy remains largely in the experimental stage but is being intensively researched in the following areas:

Prevention and treatment of age-related diseases (e.g., atherosclerosis, dementia)
Oncology: inhibition of telomerase in cancer cells to halt their uncontrolled growth
Regenerative medicine and stem cell therapy
Anti-aging medicine and longevity research
Treatment of rare diseases characterized by accelerated telomere shortening, such as dyskeratosis congenita

Opportunities and Risks

Telomere biology therapy presents both significant medical opportunities and notable risks. On one hand, there is hope for delaying age-related diseases and improving quality of life in old age. On the other hand, uncontrolled activation of telomerase carries the risk of promoting cancer, since telomerase is active in virtually all cancer cells and enables their unlimited replicative capacity. Therefore, precise and cell-type-specific control mechanisms are essential for safe clinical application.

Current State of Research

Telomere biology research is a rapidly growing field. Nobel laureate Elizabeth Blackburn and her colleagues were awarded the Nobel Prize in Physiology or Medicine in 2009 for their discovery of telomeres and telomerase. Since then, numerous clinical trials have been initiated to investigate the safety and efficacy of various telomere-based therapies. Some substances are already commercially available as dietary supplements, although their clinical efficacy in humans has not yet been conclusively established.

References

Blackburn E.H., Epel E.S., Lin J. - Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science, 2015; 350(6265): 1193-1198.
de Jesus B.B., Blasco M.A. - Telomerase at the intersection of cancer and aging. Trends in Genetics, 2013; 29(9): 513-520.
World Health Organization (WHO) - Ageing and health. Fact sheet, 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.